Cardiovascular disease, inflammation, and periodontal infection
2007; Wiley; Volume: 44; Issue: 1 Linguagem: Inglês
10.1111/j.1600-0757.2006.00196.x
ISSN1600-0757
AutoresDavid W. Paquette, Nadine Brodala, Timothy C. Nichols,
Tópico(s)Infective Endocarditis Diagnosis and Management
ResumoPeriodontology 2000Volume 44, Issue 1 p. 113-126 Cardiovascular disease, inflammation, and periodontal infection David W. Paquette, David W. PaquetteSearch for more papers by this authorNadine Brodala, Nadine BrodalaSearch for more papers by this authorTimothy C. Nichols, Timothy C. NicholsSearch for more papers by this author David W. Paquette, David W. PaquetteSearch for more papers by this authorNadine Brodala, Nadine BrodalaSearch for more papers by this authorTimothy C. Nichols, Timothy C. NicholsSearch for more papers by this author First published: 01 May 2007 https://doi.org/10.1111/j.1600-0757.2006.00196.xCitations: 67Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Taylor PR, Mark SD. Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int J Epidemiol 2005: 34: 467–474. 10.1093/ije/dyh375 PubMedWeb of Science®Google Scholar 2 Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. J Am Med Assoc 2001: 286: 64–70. 10.1001/jama.286.1.64 CASPubMedWeb of Science®Google Scholar 3 Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991: 11: 1223–1230. 10.1161/01.ATV.11.5.1223 CASPubMedWeb of Science®Google Scholar 4 American Heart Association. Heart, disease and stroke statistics – 2004 update. Dallas, TX: American Heart Association, 2003. Web of Science®Google Scholar 5 Arbes SJ. Slade GD. and Beck JD. Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III Data. J Dent Res 1999: 78: 1777–1782. 10.1177/00220345990780120301 PubMedWeb of Science®Google Scholar 6 Beck JD, Garcia R, Heiss G, Vokonas P, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996: 67: 1123–1137. 10.1902/jop.1996.67.10s.1123 CASWeb of Science®Google Scholar 7 Beck JD, Offenbacher S, Williams RC, Gibbs P, Garcia K. Periodontitis: a risk factor for coronary heart disease? Ann Periodontol 1998: 3: 127–141. 10.1902/annals.1998.3.1.127 CASPubMedGoogle Scholar 8 Beck J, Elter J, Heiss G, Couper D, Mauriello S, Offenbacher S. Relationship of periodontal disease to carotid artery intima-media wall thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 2001: 21: 1816–1822. 10.1161/hq1101.097803 CASPubMedWeb of Science®Google Scholar 9 Beck JD, Eke P, Lin D, Madianos P, Couper D, Moss K, Elter J, Heiss G, Offenbacher S. Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults. Atherosclerosis 2005: 183: 342–348. 10.1016/j.atherosclerosis.2005.03.017 CASPubMedWeb of Science®Google Scholar 10 Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 1998: 101: 353–363. 10.1172/JCI1195 CASPubMedWeb of Science®Google Scholar 11 Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998: 394: 894–897. 10.1038/29788 CASPubMedWeb of Science®Google Scholar 12 Brodala NME, Bellinger DA, Damrongsri D, Offenbacher S, Beck J, Madianos P, Sotres D, Chang YL, Koch G, Nichols TC. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 2005: 25: 1446–1451. 10.1161/01.ATV.0000167525.69400.9c CASPubMedWeb of Science®Google Scholar 13 Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001: 345: 1583–1592. 10.1056/NEJMoa011090 CASPubMedWeb of Science®Google Scholar 14 Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003: 108: 1930–1932. 10.1161/01.CIR.0000096055.62724.C5 CASPubMedWeb of Science®Google Scholar 15 Chi H, Messas E, Levine RA, Graves DT, Amar S. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Circulation 2004: 110: 1678–1685. 10.1161/01.CIR.0000142085.39015.31 CASPubMedWeb of Science®Google Scholar 16 Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999: 138: 534–536. 10.1016/S0002-8703(99)70294-2 CASPubMedWeb of Science®Google Scholar 17 Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992: 140: 301–316. CASPubMedWeb of Science®Google Scholar 18 Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991: 251: 788–791. 10.1126/science.1990440 CASPubMedWeb of Science®Google Scholar 19 Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001: 107: 1255–1262. 10.1172/JCI11871 CASPubMedWeb of Science®Google Scholar 20 D'Aiuto F, Ready D, Tonetti MS. Periodontal disease and C-reactive protein-associated cardiovascular risk. J Periodontal Res 2004: 39: 236–241. 10.1111/j.1600-0765.2004.00731.x CASPubMedWeb of Science®Google Scholar 21 Daly CG, Mitchell DH, Highfield JE, Grossberg DE, Stewart D. Bacteremia due to periodontal probing: a clinical and microbiological investigation. J Periodontol 2001: 72: 210–214. 10.1902/jop.2001.72.2.210 CASPubMedWeb of Science®Google Scholar 22 De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995: 96: 60–68. 10.1172/JCI118074 CASPubMedWeb of Science®Google Scholar 23 Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 1998: 66: 5337–5343. 10.1111/j.0300-9475.2004.01511.x CASPubMedWeb of Science®Google Scholar 24 DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. Br Med J 1993: 306: 688–691. 10.1136/bmj.306.6879.688 CASPubMedWeb of Science®Google Scholar 25 Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR Jr, Sacco RL, Papapanou PN. Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 2005: 111: 576–582. 10.1161/01.CIR.0000154582.37101.15 PubMedWeb of Science®Google Scholar 26 Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells implications for the metabolic syndrome and atherothrombosis. Circulation 2003: 107: 398–404. 10.1161/01.CIR.0000052617.91920.FD CASPubMedWeb of Science®Google Scholar 27 Elter JR, Champagne CM, Offenbacher S, Beck JD. Relationship of periodontal disease and tooth loss to prevalence of coronary heart disease. J Periodontol 2004: 75: 782–790. 10.1902/jop.2004.75.6.782 PubMedWeb of Science®Google Scholar 28 Elter JR, Hinderliter AL, Offenbacher S, Beck JD, Caughey M, Brodala N, Madianos PN. The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am Heart J 2006: 151: 47.e1–47.e6. Google Scholar 29 Engebretson SP, Lamster IB, Elkind MS, Rundek T, Serman NJ, Demmer RT, Sacco RL, Papapanou PN, Desvarieux M. Radiographic measures of chronic periodontitis and carotid artery plaque. Stroke 2005: 36: 561–566. 10.1161/01.STR.0000155734.34652.6c PubMedWeb of Science®Google Scholar 30 Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999: 398: 718–723. 10.1038/19546 CASPubMedWeb of Science®Google Scholar 31 Giacona MB, Pappanou PN, Lamster IB, Rong LL, D'Agati VD, Schmidt AM, Lalla E. Porphyromonas gingivalis induces uptake by human macrophages and promotes foam cell formation in vitro. FEMS Microbiol Lett 2004: 241: 95–101. 10.1016/j.femsle.2004.10.009 CASPubMedWeb of Science®Google Scholar 32 Gibson FC III, Hong C, Chou HH, Yumoto H, Chen J, Lien E, Wong J, Genco CA. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004: 109: 2801–2806. 10.1161/01.CIR.0000129769.17895.F0 CASPubMedWeb of Science®Google Scholar 33 Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 2000: 902: 230–239. 10.1111/j.1749-6632.2000.tb06318.x CASPubMedWeb of Science®Google Scholar 34 Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987: 316: 1371–1375. 10.1056/NEJM198705283162204 CASPubMedWeb of Science®Google Scholar 35 Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. J Am Med Assoc 2003: 290: 891–897. 10.1001/jama.290.7.891 PubMedWeb of Science®Google Scholar 36 Hackett D, Davies G, Maseri A. Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. Eur Heart J 1988: 9: 1317–1323. 10.1093/oxfordjournals.eurheartj.a062449 CASPubMedWeb of Science®Google Scholar 37 Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000: 71: 1554–1560. 10.1902/jop.2000.71.10.1554 CASPubMedWeb of Science®Google Scholar 38 Haynes WG, Stanford C. Periodontal disease and atherosclerosis: from dental to arterial plaque. Arterioscler Thromb Vasc Biol 2003: 23: 1309–1311. 10.1161/01.ATV.0000087144.24654.71 CASPubMedWeb of Science®Google Scholar 39 Herzberg ME, Meyer MW. Dental plaque, platelets and cardiovascular diseases. Ann Periodontol 1998: 3: 152–160. 10.1902/annals.1998.3.1.151 Google Scholar 40 Herzberg MC, Myer MW. Effects of oral flora on platelets: possible consequences in cardiovascular disease. J Periodontol 1996: 67: 1138–1142. 10.1902/jop.1996.67.10s.1138 PubMedWeb of Science®Google Scholar 41 Hinode D, Nakamura R, Grenier D, Mayrand D. Cross-reactivity of specific antibodies directed to heat shock proteins from periodontopathogenic bacteria and of human origin. Oral Microbiol Immunol 1998: 13: 55–58. 10.1111/j.1399-302X.1998.tb00752.x CASPubMedWeb of Science®Google Scholar 42 Horton DB, Libby P, Schonbeck U. Ligation of CD40 on vascular smooth muscle cells mediates loss of interstitial collagen via matrix metalloproteinase activity. Ann N Y Acad Sci 2001: 947: 329–336. 10.1111/j.1749-6632.2001.tb03957.x CASPubMedWeb of Science®Google Scholar 43 Howell TH, Ridker PM, Ajani UA, Hennekens CH, Christen WG. Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians. J Am Coll Cardiol 2001: 37: 445–450. 10.1016/S0735-1097(00)01130-X CASPubMedWeb of Science®Google Scholar 44 Hujoel PP, Drangsholt M, Spiekerman C, Depouen TA. Periodontal disease and coronary heart disease risk. JAMA 2000: 284: 1406–1410. 10.1001/jama.284.11.1406 CASPubMedWeb of Science®Google Scholar 45 Hung HC, Joshipura KJ, Colditz G, Manson JE, Rimm EB, Speizer FE, Willet WC. The association between tooth loss and coronary heart disease in men and women. J Public Health Dent 2004: 64: 209–215. 10.1111/j.1752-7325.2004.tb02755.x CASPubMedWeb of Science®Google Scholar 46 Ide M, Jagdev D, Coward PY, Crook M, Barclay GR, Wilson RF. The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. J Periodontol 2004: 75: 420–428. 10.1902/jop.2004.75.3.420 CASPubMedWeb of Science®Google Scholar 47 Jabs WJ, Theissing E, Nitschke M, Bechtel JF, Duchrow M, Mohamed S, Jahrbeck B, Sievers HH, Steinhoff J, Bartels C. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 2003: 108: 1428–1431. 10.1161/01.CIR.0000092184.43176.91 CASPubMedWeb of Science®Google Scholar 48 Joshipura KJ, Rimm EB, Douglas CW, Trichopoulos D, Ascherio A, Willett WC. Poor oral health and coronary heart disease. J Dent Res 1996: 75: 1631–1636. 10.1177/00220345960750090301 CASPubMedWeb of Science®Google Scholar 49 Joshipura KJ, Wand HC, Merchant AT, Rimm EB. Periodontal disease and biomarkers related to cardiovascular disease. J Dent Res 2004: 83: 151–155. 10.1177/154405910408300213 CASPubMedWeb of Science®Google Scholar 50 Kannel WB. High-density lipoproteins epidemiologic profile and risks of coronary artery disease. Am J Cardiol 1983: 52(Suppl.): 9B–12B. 10.1016/0002-9149(83)90649-5 CASPubMedWeb of Science®Google Scholar 51 Khader YS, Albashaireh ZS, Alomari MA. Periodontal diseases and the risk of coronary heart and cerebrovascular diseases: a meta-analysis. J Periodontol 2004: 75: 1046–1053. 10.1902/jop.2004.75.8.1046 PubMedWeb of Science®Google Scholar 52 Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SE, Lincoff AM, Topol EJ. Prevalence of conventional risk factors in patients with coronary heart disease. J Am Med Assoc 2003: 290: 898–904. 10.1001/jama.290.7.898 PubMedWeb of Science®Google Scholar 53 Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995: 92: 1084–1088. 10.1161/01.CIR.92.5.1084 CASPubMedWeb of Science®Google Scholar 54 Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, Tucker S, Lu Y, Papapanou PN, Schmidt AM. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003: 23: 1405–1411. 10.1161/01.ATV.0000082462.26258.FE CASPubMedWeb of Science®Google Scholar 55 LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. J Am Med Assoc 1999: 282: 2340–2346. 10.1001/jama.282.24.2340 CASPubMedWeb of Science®Google Scholar 56 Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993: 13: 197–204. 10.1161/01.ATV.13.2.197 PubMedWeb of Science®Google Scholar 57 Li L, Messas E, Batista EL Jr, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002: 105: 861–867. 10.1161/hc0702.104178 PubMedWeb of Science®Google Scholar 58 Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006: 83(Suppl.): 456S–460S. CASPubMedWeb of Science®Google Scholar 59 Libby P, Ordovas JM, Auger KR, Robbins AH, Birinyi LK, Dinarello CA. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol 1986: 124: 179–185. CASPubMedWeb of Science®Google Scholar 60 Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002: 105: 1135–1143. 10.1161/hc0902.104353 CASPubMedWeb of Science®Google Scholar 61 Loree HM, Kamm RD, Stringfellow RG, Lee RT. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 1992: 71: 850–858. 10.1161/01.RES.71.4.850 CASPubMedWeb of Science®Google Scholar 62 Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997: 96: 396–399. 10.1161/01.CIR.96.2.396 CASPubMedWeb of Science®Google Scholar 63 Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998: 394: 200–203. 10.1038/28204 CASPubMedWeb of Science®Google Scholar 64 Mach F, Sauty A, Iarossi AS, Sukhova GK, Neote K, Libby P, Luster AD. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 1999: 104: 1041–1050. 10.1172/JCI6993 CASPubMedWeb of Science®Google Scholar 65 Matilla K, Nieminen M, Valtonen V, Rasi V, Kesaniemi Y, Syrjala S, Jungul P, Isoluoma M, Hietaniemi K, Jokinen M, Huttunen J. Association between dental health and acute myocardial infarction. Br Med J 1989: 298: 779–782. 10.1136/bmj.298.6676.779 PubMedWeb of Science®Google Scholar 66 Matilla KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi KL. Dental infections and coronary atherosclerosis. Atherosclerosis 1993: 103: 205–211. 10.1016/0021-9150(93)90263-T PubMedWeb of Science®Google Scholar 67 Meurman JH, Sanz M, Janket SJ. Oral health, atherosclerosis and cardiovascular disease. Crit Rev Oral Biol Med 2004: 15: 403–413. 10.1177/154411130401500606 PubMedWeb of Science®Google Scholar 68 Mora S, Ridker PM. Justification for the use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) – can C-reactive protein be used to target statin therapy in primary prevention? Am J Cardiol 2006: 97(Suppl.): 33A–41A. 10.1016/j.amjcard.2005.11.014 CASPubMedWeb of Science®Google Scholar 69 MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002: 360: 7–22. 10.1016/S0140-6736(02)09327-3 CASPubMedWeb of Science®Google Scholar 70 Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN: REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. J Am Med Assoc 2004: 291: 1071–1080. 10.1001/jama.291.9.1071 CASPubMedWeb of Science®Google Scholar 71 O'Connor S, Taylor C, Campbell LA, Epstein S, Libby P. Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis 2001: 7: 780–787. 10.3201/eid0705.010503 CASPubMedWeb of Science®Google Scholar 72 Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000: 102: 2165–2168. 10.1161/01.CIR.102.18.2165 CASPubMedWeb of Science®Google Scholar 73 Pussinen PJ, Alfthan G, Rissanen H, Reunanen A, Asikainen S, Knekt P. Antibodies to periodontal pathogens and stroke risk. Stroke 2004: 35: 2020–2023. 10.1161/01.STR.0000136148.29490.fe PubMedWeb of Science®Google Scholar 74 Pussinen PJ, Nyyssonen K, Alfthan G, Salonen R, Laukkanen JA, Salonen JT. Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler Thromb Vasc Biol 2005: 25: 833–838. 10.1161/01.ATV.0000157982.69663.59 CASPubMedWeb of Science®Google Scholar 75 Rajavashisth T, Qiao JH, Tripathi S, Tripathi J, Mishra N, Hua M, Wang XP, Loussararian A, Clinton S, Libby P, Lusis A. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 1998: 101: 2702–2710. 10.1172/JCI119891 CASPubMedWeb of Science®Google Scholar 76 Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997: 336: 973–979. 10.1056/NEJM199704033361401 CASPubMedWeb of Science®Google Scholar 77 Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000: 342: 836–843. 10.1056/NEJM200003233421202 CASPubMedWeb of Science®Google Scholar 78 Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002: 347: 1557–1565. 10.1056/NEJMoa021993 CASPubMedWeb of Science®Google Scholar 79 Rosenfeld ME, Yla-Herttuala S, Lipton BA, Ord VA, Witztum JL, Steinberg D. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol 1992: 140: 291–300. PubMedWeb of Science®Google Scholar 80 Saren P, Welgus HG, Kovanen PT. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996: 157: 4159–4165. 10.4049/jimmunol.157.9.4159 CASPubMedWeb of Science®Google Scholar 81 Scannapieco FA, Bush RB, Paju S. Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol 2003: 8: 38–53. 10.1902/annals.2003.8.1.38 PubMedGoogle Scholar 82 Schonbeck U, Sukhova GK, Shimizu K, Mach F, Libby P. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Natl Acad Sci U S A 2000: 97: 7458–7463. 10.1073/pnas.97.13.7458 CASPubMedWeb of Science®Google Scholar 83 Sconyers JR, Crawford JJ, Moriarty JD. Relationship of bacteremia to toothbrushing in patients with periodontitis. J Am Dent Assoc 1973: 87: 616–622. 10.14219/jada.archive.1973.0453 CASPubMedWeb of Science®Google Scholar 84 Seinost G, Wimmer G, Skerget M, Thaller E, Brodmann M, Gasser R, Bratschko RO, Pilger E. Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J 2005: 149: 1050–1054. 10.1016/j.ahj.2004.09.059 PubMedWeb of Science®Google Scholar 85 Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003: 361: 1149–1158. 10.1016/S0140-6736(03)12948-0 CASPubMedWeb of Science®Google Scholar 86 Silver JG, Martin AW, McBride BC. Experiment transient bacteremias in human subjects with varying degrees of plaque accumulation and gingival inflammation. J Clin Periodontol 1980: 4: 92–99. 10.1111/j.1600-051X.1977.tb01888.x Web of Science®Google Scholar 87 Sims TJ, Lernmark A, Mancl LA, Schifferle RE, Page RC, Persson GR. Serum IgG to heat shock proteins and Porphyromonas gingivalis antigens in diabetic patients with periodontitis. J Clin Periodontol 2002: 29: 551–562. 10.1034/j.1600-051X.2002.290612.x CASPubMedWeb of Science®Google Scholar 88 Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 2000: 79: 49–57. 10.1177/00220345000790010701 CASPubMedWeb of Science®Google Scholar 89 Smith SC. Current and future directions of cardiovascular risk prediction. Am J Cardiol 2006: 97(Suppl.): 28A–32A. 10.1016/j.amjcard.2005.11.013 PubMedWeb of Science®Google Scholar 90 Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 1995: 92: 8264–8268. 10.1073/pnas.92.18.8264 CASPubMedWeb of Science®Google Scholar 91 Söder PO, Söder B, Nowak J, Jogestrand T. Early carotid atherosclerosis in subjects with periodontal diseases. Stroke 2005: 36: 1195–1200. 10.1161/01.STR.0000165916.90593.cb PubMedWeb of Science®Google Scholar 92 Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999: 99: 2503–2509. 10.1161/01.CIR.99.19.2503 CASPubMedWeb of Science®Google Scholar 93 Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 2002: 106: 2055–2060. 10.1161/01.CIR.0000034508.55617.65 CASPubMedWeb of Science®Google Scholar 94 Tuzcu EM, Kapadia SR, Tutar E, Ziada KM, Hobbs RE, McCarthy PM, Young JB, Nissen SE. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001: 103: 2705–2710. 10.1161/01.CIR.103.22.2705 CASPubMedWeb of Science®Google Scholar 95 Umino M, Nagao M. Systemic diseases in elderly dental patients. Int Dent J 1993: 43: 213–218. CASPubMedGoogle Scholar 96 Van De Ree MA, Huisman MV, Princen HM, Meinders AE, Kluft C. Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis 2003: 166: 129–135. 10.1016/S0021-9150(02)00316-7 CASPubMedWeb of Science®Google Scholar 97 Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwalam MV, Dhillon B, Weisel RD Li RK, Mickle DA, Stewart DJ. A self-fulfilling prophecy C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002: 106: 913–919. 10.1161/01.CIR.0000029802.88087.5E CASPubMedWeb of Science®Google Scholar 98 Vettore MV. Periodontal disease and cardiovascular disease. Evid Based Dent 2004: 5: 69. 10.1038/sj.ebd.6400272 PubMedGoogle Scholar 99 Virmani R, Robinowitz M, Geer JC, Breslin PP, Beyer JC, McAllister HA. Coronary artery atherosclerosis revisited in Korean war combat casualties. Arch Pathol Lab Med 1987: 111: 972–976. CASPubMedWeb of Science®Google Scholar 100 World Health Organization. The World Health Report 1997. Geneva: World Health Organization, 1997. 10.1596/978-0-1952-1114-6 Google Scholar 101 Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT. An examination of the relation between periodontal health status and cardiovascular risk factors. Serum total and HDL cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol 2000: 85: 180–189. Google Scholar 102 Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages implications for atherosclerosis. Circulation 2001: 103: 1194–1197. 10.1161/01.CIR.103.9.1194 CASPubMedWeb of Science®Google Scholar Citing Literature Volume44, Issue1June 2007Pages 113-126 ReferencesRelatedInformation
Referência(s)